PIERIS PHARMACEUTICALS, INC. 4
4 · PIERIS PHARMACEUTICALS, INC. · Filed Mar 6, 2017
Insider Transaction Report
Form 4
Yoder Stephen S.
DirectorCEO and President
Transactions
- Award
Stock Option (Right to buy)
2017-02-23+434,350→ 434,350 totalExercise: $1.99Exp: 2027-02-23→ Common Stock (434,350 underlying)
Footnotes (1)
- [F1]The option vests as to 25% of the option shares on January 1, 2018 and vests as to an additional 6.25% of the option shares at the end of each successive three-month period thereafter.